Intelligence · Clinical pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
Pipeline programs
-
Tirzepatide
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Tirzepatide
Grace Therapeutics
Prader-Willi Syndrome
1 trial -
Tislelizumab
The First People's Hospital of Lianyungang
Advanced NSCLC
1 trial -
Tislelizumab + cisplatin + paclitaxel
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Tocilizumab
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Tocilizumab
Shanghai Zhongshan Hospital
Takayasu Arteritis
1 trial -
Tofacitinib and Acitretin Capsules.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Cutaneous Amyloidosis
1 trial -
Tofacitinib with methotrexate
Pfizer
Rhematoid Arthritis
1 trial -
Tolvaptan
Otsuka Beijing Research Institute
Hyponatremia and Extracellular Fluid in Cirrhotic
1 trial -
Topical Anesthetic
Hospital Authority, Hong Kong
Radial Artery Spasm
1 trial -
Topiramate
United Therapeutics Europe Ltd
PTSD
1 trial -
Topiramate
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
Topiramate
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Alcohol Dependence
1 trial -
Topiramate
United Therapeutics Europe Ltd
Traumatic Brain Injury (TBI)
1 trial -
Topiramate
Janssen Cilag International NV
Epilepsy
1 trial -
Toripalimab
Coherus Oncology
Nasopharyngeal Cancer Recurrent
1 trial -
Toujeo
Almirall, S.A.
Diabetes Mellitus, Type 2
1 trial -
Tramadol HCI/acetaminophen
Janssen-Cilag Pty Ltd
Cancer
1 trial -
Tranexamic Acid
The First People's Hospital of Lianyungang
Postpartum Hemorrhage, Cesarean Section
1 trial -
Tranexamic Acid 1000 mg/10ml normal saline infusion
United Therapeutics Europe Ltd
Postpartum Hemorrhage
1 trial -
Trangorex 200 mg comprimidos
The George Institute
Atrial fibrillation
1 trial -
Transanal irrigation with Peristeen Anal Irrigation
Stoke Therapeutics
Constipation
1 trial -
Transdermal Nicotine Patch
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
Transdermal nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Transepicardial with Transseptal CD 133+ Implantation
Hospital Authority, Hong Kong
Coronary Artery Disease
1 trial -
Transmucosal Buprenorphine
Indivior Pty Ltd
Moderate to Severe Opioid-use Disorder
1 trial -
Trastuzumab Rezetecan
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Trazodone
United Therapeutics Europe Ltd
Sleep Apnea
1 trial -
Treatment Algorithm A
Takeda
Colitis, Ulcerative
1 trial -
Treatment group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Trelagliptin
Takeda
Type 2 Diabetes Mellitus
2 trials -
Trelagliptin
Takeda
Type 2 Diabetes
1 trial -
Treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
3 trials -
Triamcinolone acetonide-Ketorolac-Ropivacaine
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
Trimebutine 100 MG
Hospital Authority, Hong Kong
Helicobacter Pylori Infection
1 trial -
Trimetazidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Triple antithrombotic therapy
The First People's Hospital of Lianyungang
Acute Coronary Syndrome (ACS)
1 trial -
Triple combination therapy group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
Triptergium Wilfordii
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis Vulgaris
1 trial -
Trivalent live attenuated seasonal influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial -
Two doses of quadrivalent influenza vaccine
Sinovac Research and Development Co.,
Seasonal Influenza
1 trial -
Typhoid Vi vaccine
International Peace Maternity and Child Health Hospital
Typhoid
1 trial -
UNI-BETAIN
Lacuna Pharma Pty Ltd
Functional Dyspepsia
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis
4 trials -
Ultomiris 300 mg/30 mL concentrate for solution for infusion
The George Institute
IgA nephropathy
1 trial -
Ultomiris 300 mg/30 mL concentrate for solution for infusion
Disc Medicine
Paroxysmal nocturnal hemoglobinuria (PNH)
1 trial -
Ursodeoxycholic acid combined with total glucosides of paeony
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis
1 trial -
Use of Mitomycin-C (MMC) in trabeculectomy
AEON Biopharma
Glaucoma
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.